Optimizing Monoclonal Antibody Production: High-Yield Upstream Process Intensification Strategies

Monoclonal antibody manufacturers face growing pressure to increase output while controlling costs, resource use, and operational complexity. An integrated process intensification strategy can help meet these demands by combining high-density cell banking, N-1 perfusion, optimized cell culture media, intensified bioreactor operation, and single-use harvest technologies. Modeled comparisons show how these approaches may increase titers, shorten timelines, reduce seed-train requirements, and improve facility utilization. The analysis also examines potential gains in throughput, manufacturing cost, consumable use, labor efficiency, and sustainability across upstream and downstream workflows.

Explore the technical and economic considerations behind a more productive, flexible approach to monoclonal antibody manufacturing.